USD 0.0
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | 26.05 Million | 6.35 Million |
Net Income | - | - | - | - | -152.91 Million | -143.24 Million |
Depreciation & Amortization | - | - | - | - | 57.27 Million | 59.91 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | 1.93 Million | 2.94 Million |
Change in working capital | - | - | - | - | 51.51 Million | 65.12 Million |
Other non-cash items | - | - | - | - | 125.52 Million | 81.53 Million |
Investing Cash Flow | - | - | - | - | -61.01 Million | -19.29 Million |
Investments in PPE | - | - | - | - | -61.01 Million | -19.29 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | 49.91 Million | 6.07 Million |
Debt repayment | - | - | - | - | -9.24 Million | -449 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | -717 Thousand | -228 Thousand |
Common Stock Issuance | - | - | - | - | - | 364 Thousand |
Other Financing Activities | - | - | - | - | 59.87 Million | 6.75 Million |
Accounts receivables | - | - | - | - | -3.49 Million | 630 Thousand |
Accounts payables | - | - | - | - | 54.37 Million | 66.14 Million |
Inventory | - | - | - | - | 2.09 Million | -1.46 Million |
Other working capital | - | - | - | - | 49.42 Million | 65.96 Million |
Cash at beginning of period | - | - | - | - | 7.17 Million | 8.36 Million |
Cash at end of period | - | - | - | - | 22.13 Million | 7.17 Million |
Capital Expenditure | - | - | - | - | -61.01 Million | -19.29 Million |
Effect of forex changes on cash | - | - | - | - | - | 5.67 Million |
Net cash flow / Change in cash | - | - | - | - | 14.95 Million | -1.18 Million |
Free Cash Flow | - | - | - | - | -34.95 Million | -12.93 Million |
Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2017 FY | 2017 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | -152.91 Million | -12.86 Million |
Depreciation & Amortization | - | - | - | - | 57.27 Million | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | 1.93 Million | 313 Thousand |
Change in working capital | - | - | - | - | 51.51 Million | 20.99 Million |
Other non-cash items | - | - | - | - | 125.52 Million | 3.06 Million |
Investing Cash Flow | - | - | - | - | -61.01 Million | -19.35 Million |
Investments in PPE | - | - | - | - | -61.01 Million | -19.35 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | 49.91 Million | 11.85 Million |
Debt repayment | - | - | - | - | -9.24 Million | -4.57 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | -717 Thousand | -9000.00 |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | 59.87 Million | 16.44 Million |
Accounts receivables | - | - | - | - | -3.49 Million | - |
Accounts payables | - | - | - | - | 54.37 Million | - |
Inventory | - | - | - | - | 2.09 Million | -1.92 Million |
Other working capital | - | - | - | - | 49.42 Million | 22.91 Million |
Cash at beginning of period | - | - | - | - | 7.17 Million | 18.13 Million |
Cash at end of period | - | - | - | - | 22.13 Million | 22.13 Million |
Capital Expenditure | - | - | - | - | -61.01 Million | -19.35 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | 14.95 Million | 4 Million |
Free Cash Flow | - | - | - | - | -34.95 Million | -7.85 Million |
VPK
ORL
GLOP-PC
EPD
EGY
002960